Trusted Resources: Education
Scientific literature and patient education texts
Mucopolysaccharidosis Type I Diagnosed by Aortic and Mitral Valve Replacement
source: JACC. Case reports
year: 2021
authors: Sherwood DJ,Adams MC,Mazzella AJ,Abid A,Prasada S,Muenzer J,Johnson SM,Yeung M
summary/abstract:A 32-year-old developmentally delayed man presenting with dyspnea was found to have severe aortic and mitral valve stenosis. After double valve replacement, unique histologic findings prompted a genetics evaluation, ultimately leading to the diagnosis of mucopolysaccharidosis type I, a rare lysosomal storage disorder with high rates of cardiac manifestations. ().
organization: Department of Medicine, University of North Carolina Hospitals, Chapel Hill, North Carolina, USA.DOI: 10.1016/j.jaccas.2021.10.013
read more
Related Content
-
In Silico Analysis of Potential Off-Target Sites to Gene Editing for Mucopolysaccharidosis Type I Using the CRISPR/C...Mucopolysaccharidosis type I (MPS I) is ...
-
Mucopolysacharidosis Type I Presenting as Bipolar Affective Disorder: A Case ReportMucopolysacharidosis type I is a multisy...
-
Mucopolysaccharidoses Type I Gene TherapyMucopolysaccharidoses type I (MPS I) is ...
-
UPMC Children’s Hospital of Pittsburgh – Center for Rare Disease TherapyHurler syndrome (mucopolysaccharidosis t...
-
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler SyndromeAllogeneic hematopoietic stem-cell trans...
-
Lysosomal Storage Disorders: Clinical, Biochemical and Molecular Profile From Rare Disease Centre, IndiaLysosomal storage disorders (LSDs) are a...
-
UCSF – Lysosomal Storage Disease CenterThe UCSF Lysosomal Storage Disease Cente...